ScholarIQanswers from OpenAlex
OLVG
InstitutionResearch output, impact & collaborations
OLVG is a institution indexed in ScholarIQ from OpenAlex.
What is known about OLVG?
ScholarIQrecord summary
OLVG is a research organisation in Amsterdam, NL. OpenAlex records 7,267 works and 520,723 citations for it. 1,844 researchers list it as their most recent affiliation.
How many works does OLVG have?
ScholarIQindexed works
OLVG has 7,267 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does OLVG have?
ScholarIQcitation count
OLVG has 520,723 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at OLVG?
ScholarIQresearcher count
OLVG has 1,844 researchers in the ScholarIQ index.
What is the average h-index at OLVG?
ScholarIQavg h-index
OLVG has an average h-index of 15 in OpenAlex.
What is the OpenAlex record for OLVG?
ScholarIQopenalex
The OpenAlex for OLVG is on the source record.
Who are the most-cited researchers behind OLVG?
ScholarIQtop researchers by citations
What are the most-cited papers on OLVG?
ScholarIQmost cited works
Development of Ulcer Disease After Roux-en-Y Gastric Bypass, Incidence, Risk Factors, and Patient Presentation: A Systematic Review
Usha K. Coblijn, Amin B. Goucham, Sjoerd M. Lagarde, Sjoerd D. Kuiken, Bart A. van Wagensveld
The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double blind, randomized, placebo-controlled study
Sjoerd D. Kuiken, Guido N.J. Tytgat, Guy E. Boeckxstaens
Development of a test to measure gastric accommodation in humans
Sjoerd D. Kuiken, Melvin Samsom, Michael Camilleri, Brian P. Mullan, Duane D. Burton, Louis J. Kost, Timothy J. Hardyman, Benjamin H. Brinkmann, Michael K. O’Connor
Urgent endoscopic retrograde cholangiopancreatography with sphincterotomy versus conservative treatment in predicted severe acute gallstone pancreatitis (APEC): a multicentre randomised controlled trial
Nicolien J. Schepers, Nora D. Hallensleben, Marc G. Besselink, Marie-Paule Anten, Thomas L. Bollen, David W. da Costa, Foke van Delft, Sven M. van Dijk, Hendrik M. van Dullemen, Marcel G. W. Dijkgraaf, Casper H.J. van Eijck, G Willemien Erkelens, Nicole S. Erler, Paul Fockens, Erwin J. M. van Geenen, Janneke van Grinsven, Robbert A. Hollemans, Jeanin E. van Hooft, R.W.M. van der Hulst, Jeroen M. Jansen, F J G M Kubben, Sjoerd D. Kuiken, Robert J.F. Laheij, Rutger Quispel, Rogier J. J. de Ridder, M. Rijk, Tessa E H Römkens, Carola H.M. Ruigrok, Erik J. Schoon, Matthijs P. Schwartz, Xavier J.N.M. Smeets, B.W.M. Spanier, Adriaan C.I.T.L. Tan, Willem Thijs, Robin Timmer, Niels G. Venneman, Robert C. Verdonk, Frank P. Vleggaar, Wim van de Vrie, Ben Witteman, Hjalmar C. van Santvoort, Olaf J. Bakker, Marco J. Bruno
No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study
Brenda Hermsen, R.I. Olivier, René H.M. Verheijen, Marc van Beurden, Joanne A. de Hullu, Leon F.A.G. Massuger, Curt W. Burger, Cecile T.M. Brekelmans, M J E Mourits, Geertruida H. de Bock, Katja N. Gaarenstroom, Hester H. van Boven, Thea M. Mooij, Matti A. Rookus
How much of the research on OLVG is open access?
ScholarIQopen access share
50%OPEN ACCESS